Sector: Healthcare | Industry: Healthcare Facilities & Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 35 West 35th St., Floor 6 NEW YORK NY 10001 |
Tel: | N/A |
Website: | https://www.docgo.com |
IR: | See website |
Key People | ||
Lee Bienstock Chief Executive Officer, Director | Norman Rosenberg Chief Financial Officer | Andre Oberholzer Executive Vice President - Capital Markets and Strategy, Treasurer |
Stephen Sugrue Chief Compliance Officer | Ely D. Tendler General Counsel, Company Secretary, Director |
Business Overview |
DocGo Inc. is a healthcare transportation and mobile services company. The Company uses dispatch and communication technology to help provide healthcare transportation and mobile services in-person medical treatment directly to patients in the comfort of their homes, workplaces, and other non-traditional locations, in metropolitan cities in the United States and the United Kingdom. Its segments include Mobile Health Services, Transportation Services and Corporate. Mobile Health Services include a wide variety of healthcare services performed at homes, offices and other locations and event services such as on-site healthcare support at sporting events and concerts. Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports. Corporate segment represents shared services and personnel that support both the Transportation Services and Mobile Health Services segments. |
Financial Overview |
For the three months ended 31 March 2024, DocGo Inc revenues increased 70% to $192.1M. Net income totaled $11.2M vs. loss of $3.5M. Revenues reflect Mobile Health Services segment increase of 97% to $143.9M, Transportation Services segment increase of 20% to $48.1M, United States segment increase of 81% to $179.1M. Net Income reflects Mobile Health Services segment income increase from $13.2M to $32.2M. |
Employees: | 2,915 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $326.41M as of Mar 31, 2024 |
Annual revenue (TTM): | $703.37M as of Mar 31, 2024 |
EBITDA (TTM): | $68.56M as of Mar 31, 2024 |
Net annual income (TTM): | $21.55M as of Mar 31, 2024 |
Free cash flow (TTM): | -$60.21M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $1.40M as of Mar 31, 2024 |
Shares outstanding: | 101,565,541 as of May 6, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |